Role of "metabolic" tissue remodeling in the pathophysiology of obesity-induced chronic inflammation
Project/Area Number |
16H05171
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Experimental pathology
|
Research Institution | Nagoya University |
Principal Investigator |
|
Research Collaborator |
Itoh Michiko
|
Project Period (FY) |
2016-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥17,680,000 (Direct Cost: ¥13,600,000、Indirect Cost: ¥4,080,000)
Fiscal Year 2018: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2017: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2016: ¥7,540,000 (Direct Cost: ¥5,800,000、Indirect Cost: ¥1,740,000)
|
Keywords | 慢性炎症 / 肥満 / 非アルコール性脂肪肝炎 / マクロファージ / 細胞死 / メタボリックシンドローム / 組織リモデリング / 線維化 |
Outline of Final Research Achievements |
In this study, to understand the molecular mechanism underlying NASH, we employed genetically obese melanocortin-4 receptor-deficient mice, which sequentially developed simple steatosis, NASH, and hepatocellular carcinoma (HCC) when they were fed a Western diet. We also develop novel accelerated animal models which exhibited NASH and HCC in the short-term. Using these animal models, we identified a unique histological structure termed “crown-like structure”, in which macrophages aggregated around dead hepatocytes, thereby accelerating tissue remodeling during the disease progression from simple steatosis to NASH. Our data suggest that CLS is useful to examine the molecular mechanisms how certain drugs ameliorated NASH.
|
Academic Significance and Societal Importance of the Research Achievements |
近年、数多くの抗糖尿病薬が上市され、糖尿病治療は、単に血糖値を低下させるのみならず、合併症を予防することに重点が置かれるようになってきた。即ち、脂肪肝やNASHに対する抗糖尿病薬の効果が注目されている。そこで本研究では、種々の薬剤のNASHに対する薬効評価を実施した。CLSに着目することにより、治療効果の定量的評価が可能となり、作用機序の一端も明らかになるなど、今後の治療法の開発に資すると考えられた。
|
Report
(4 results)
Research Products
(27 results)
-
-
-
-
-
-
-
[Journal Article] Evaluation of hepatic function using dynamic contrast-enhanced magnetic resonance imaging in melanocortin 4 receptor-deficient mice as a model of nonalcoholic steatohepatitis.2018
Author(s)
T. Yamada, Y. Kashiwagi, T. Rokugawa, H. Kato, H. Konishi, T. Hamada, R. Nagai, Y. Masago, M. Itoh, T. Suganami, Y. Ogawa, H. Watabe, K. Abe.
-
Journal Title
Magn. Reson. Immaging
Volume: 57
Pages: 210-217
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
[Journal Article] Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis.2017
Author(s)
C. Komiya, M. Tanaka, K. Tsuchiya, N. Shimazu, K. Mori, S. Furuke, Y. Miyachi, K. Shiba, S. Yamaguchi, K. Ikeda, K. Ochi, K. Nakabayashi, K. Hata, M. Itoh, T. Suganami, Y. Ogawa.
-
Journal Title
Sci. Rep.
Volume: 7
Issue: 1
Pages: 44754-44754
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Journal Article] The H3K9 methyltransferase Setdb1 regulates TLR4-mediated inflammatory responses in macrophages.2016
Author(s)
R. Hachiya, T. Shiihashi, I. Shirakawa, Y. Iwasaki, Y. Matsumura, Y. Oishi, Y. Nakayama, Y. Miyamoto, I. Manabe, K. Ochi, M. Tanaka, N. Goda, J. Sakai, T. Suganami, Y. Ogawa.
-
Journal Title
Sci. Rep.
Volume: 6
Issue: 1
Pages: 28845-28845
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Journal Article] Inflammatory responses increase secretion of MD-1 protein.2016
Author(s)
RT. Jennings, E. Odkhuu, A. Nakashima, N. Morita, T. Kobayashi, I. Yamai, M. Tanaka, T. Suganami, S. Haga, M. Ozaki, Y. Watanabe, Y. Nagai, K. Takatsu, T. Kikuchi-Ueda, I. Ichimonji, Y. Ogawa, H. Takagi, T. Yamazaki, K. Miyake, S. Akashi-Takamura.
-
Journal Title
Int. Immunol.
Volume: 28
Pages: 503-512
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
-
[Presentation] 脂肪組織の慢性炎症2016
Author(s)
菅波孝祥、田中 都、伊藤美智子、小川佳宏
Organizer
第59回日本糖尿病学会年次学術集会
Place of Presentation
京都
Year and Date
2016-05-19
Related Report
Invited
-
-
-
-